Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
University of Rochester
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Thomas Jefferson University
Fred Hutchinson Cancer Center
Dartmouth-Hitchcock Medical Center
Masonic Cancer Center, University of Minnesota
Melbourne Health
Northside Hospital, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Liege
Memorial Sloan Kettering Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Dartmouth-Hitchcock Medical Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
Massachusetts General Hospital
H. Lee Moffitt Cancer Center and Research Institute
Beth Israel Deaconess Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Texas Oncology Cancer Center
Baylor College of Medicine
M.D. Anderson Cancer Center